Home › Compare › JWTXF vs ABBV
JWTXF yields 4.14% · ABBV yields 3.06%● Live data
📍 JWTXF pulled ahead of the other in Year 3
Combined, JWTXF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JWTXF + ABBV for your $10,000?
The Japan Wool Textile Co., Ltd. operates in the textile industry in Japan. It operates through four business lines: Textile & Clothing Materials, Industrial Machinery & Materials, Human & Future Development, and Consumer Goods & Services. The Textile & Clothing Materials business manufactures and sells knitting wool for fabric/knitting, uniform-related materials and products, and men's and women's fashion materials. The Industrial Machinery & Materials business is involved in the development, manufacture, and sale of various materials, including wool, chemical synthetic fibers, and threads through twine/felt/non-woven fabrics. It also designs, manufactures, and sells industrial machinery; and designs, installs, and maintains environmental/energy systems. The Human & Future Development business provides daycare, childcare/after-school care, small group home care, welfare equipment rental and sales, and house renovations services, as well as engages in the commercial facility operation, Children's amusement facility, ice cream, video rental, snack sales, and cellular phone businesses. It also operates tennis schools, golf courses, driving ranges, and equestrian clubs, as well as Karaoke and bowling alleys; rental of office buildings; provision of rental office management services; and sale of residential land and construction of houses. The Consumer Goods & Services business provides ballroom dance attires, office and industrial use inks, clothing, horse gear and other equestrian products, and stamps and stamp-related products and services; and insurance agency and logistics services, as well as offers beds and bedding, furniture, and other related goods online. The company was incorporated in 1896 and is headquartered in Osaka, Japan.
Full JWTXF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.